glp 1 receptor agonists in idiopathic intracranial hypertension and Excited to share our study @JAMANeuro GLP-1 RA therapy for Efficacy of glucagon-like peptide-1 receptor

The images or other third party material in this article are included in the articles Creative Commons licence, unless indicated otherwise in a credit line to the material

It reflects how each medication interacts with hormone pathways that influence appetite, insulin response, digestion, metabolism, and possibly energy expenditure

20 After 52 weeks, steatohepatitis resolved without fibrosis progression in 44%, 56%, and 62% of participants receiving tirzepatide at doses of 5 mg, 10 mg, and 15 mg, respectively, compared to 10% in the placebo group

The FDA approved Ozempic (semaglutide) to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease

142 , 13s18s (2011)

Front Physiol